FNCHQ
Finch Therapeutics Group, Inc.Company with tickers: FNCH, FNCHQ
CIK
1733257
CUSIP
31773D200
Shares Outstanding
1,605,763
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2024-10-21 | 2024-10-17 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-12 | 2024-08-09 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-05-17 | 2024-05-14 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 10-K/A | 2024-04-26 | 2023-12-31 | |
| 8-K | 2024-04-03 | 2024-03-28 | |
| 10-K | 2024-03-25 | 2023-12-31 | |
| 8-K | 2024-02-23 | 2024-02-16 | |
| 8-K | 2023-11-17 | 2023-11-15 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 10-Q/A | 2023-08-11 | 2023-06-30 | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-07-07 | 2023-06-30 | |
| 8-K | 2023-06-28 | 2023-06-27 | |
| 8-K | 2023-06-23 | 2023-06-21 | |
| 8-K | 2023-06-09 | 2023-06-08 | |
| 8-K | 2023-05-30 | 2023-05-25 | |
| 8-K | 2023-05-18 | 2023-05-12 | |
| 8-K | 2023-05-11 | 2023-05-08 | |
| 10-Q | 2023-05-10 | 2023-03-31 | |
| 8-K | 2023-05-10 | — | |
| 8-K | 2023-04-25 | 2023-04-21 | |
| 8-K | 2023-04-18 | 2023-04-12 | |
| 10-K | 2023-03-23 | 2022-12-31 | |
| 8-K | 2023-03-23 | — | |
| 8-K | 2023-01-26 | 2023-01-25 | |
| 8-K | 2023-01-24 | 2023-01-23 | |
| 8-K | 2023-01-06 | — | |
| 8-K | 2022-12-12 | — | |
| 8-K | 2022-11-14 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 8-K | 2022-11-10 | — | |
| 8-K | 2022-09-01 | — | |
| 8-K | 2022-08-25 | 2022-08-19 | |
| 8-K | 2022-08-11 | — | |
| 10-Q | 2022-08-11 | 2022-06-30 | |
| 8-K | 2022-06-16 | 2022-06-10 | |
| 10-Q | 2022-05-16 | 2022-03-31 | |
| 8-K | 2022-05-16 | — | |
| 8-K | 2022-04-28 | — | |
| 8-K | 2022-04-19 | 2022-04-14 | |
| 8-K | 2022-03-31 | — | |
| 10-K | 2022-03-31 | 2021-12-31 | |
| 8-K | 2022-03-01 | 2022-02-24 | |
| 8-K | 2022-01-10 | — | |
| 8-K | 2021-11-10 | — | |
| 10-Q | 2021-11-10 | 2021-09-30 | |
| 8-K | 2021-10-19 | — |
Showing 1–50 of 60 filings